pLX313-Renilla luciferase Citations (14)
Originally described in: Mutational processes shape the landscape of TP53 mutations in human cancer.Giacomelli AO, Yang X, Lintner RE, McFarland JM, Duby M, Kim J, Howard TP, Takeda DY, Ly SH, Kim E, Gannon HS, Hurhula B, Sharpe T, Goodale A, Fritchman B, Steelman S, Vazquez F, Tsherniak A, Aguirre AJ, Doench JG, Piccioni F, Roberts CWM, Meyerson M, Getz G, Johannessen CM, Root DE, Hahn WC Nat Genet. 2018 Oct;50(10):1381-1387. doi: 10.1038/s41588-018-0204-y. PubMed Journal
Articles Citing pLX313-Renilla luciferase
| Articles |
|---|
| Myt Transcription Factors Prevent Stress-Response Gene Overactivation to Enable Postnatal Pancreatic beta Cell Proliferation, Function, and Survival. Hu R, Walker E, Huang C, Xu Y, Weng C, Erickson GE, Coldren A, Yang X, Brissova M, Kaverina I, Balamurugan AN, Wright CVE, Li Y, Stein R, Gu G. Dev Cell. 2020 May 18;53(4):390-405.e10. doi: 10.1016/j.devcel.2020.04.003. Epub 2020 Apr 30. PubMed |
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q.
Neggers JE, Paolella BR, Asfaw A, Rothberg MV, Skipper TA, Yang A, Kalekar RL, Krill-Burger JM, Dharia NV, Kugener G, Kalfon J, Yuan C, Dumont N, Gonzalez A, Abdusamad M, Li YY, Spurr LF, Wu WW, Durbin AD, Wolpin BM, Piccioni F, Root DE, Boehm JS, Cherniack AD, Tsherniak A, Hong AL, Hahn WC, Stegmaier K, Golub TR, Vazquez F, Aguirre AJ.
Cell Rep. 2020 Dec 15;33(11):108493. doi: 10.1016/j.celrep.2020.108493.
PubMed
Associated Plasmids |
| A novel beta-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Tanton H, Sewastianik T, Seo HS, Remillard D, Pierre RS, Bala P, Aitymbayev D, Dennis P, Adler K, Geffken E, Yeoh Z, Vangos N, Garbicz F, Scott D, Sethi N, Bradner J, Dhe-Paganon S, Carrasco RD. Sci Adv. 2022 Apr 29;8(17):eabm3108. doi: 10.1126/sciadv.abm3108. Epub 2022 Apr 29. PubMed |
| Structural variants shape driver combinations and outcomes in pediatric high-grade glioma. Dubois FPB, Shapira O, Greenwald NF, Zack T, Wala J, Tsai JW, Crane A, Baguette A, Hadjadj D, Harutyunyan AS, Kumar KH, Blattner-Johnson M, Vogelzang J, Sousa C, Kang KS, Sinai C, Wang DK, Khadka P, Lewis K, Nguyen L, Malkin H, Ho P, O'Rourke R, Zhang S, Gold R, Deng D, Serrano J, Snuderl M, Jones C, Wright KD, Chi SN, Grill J, Kleinman CL, Goumnerova LC, Jabado N, Jones DTW, Kieran MW, Ligon KL, Beroukhim R, Bandopadhayay P. Nat Cancer. 2022 Aug;3(8):994-1011. doi: 10.1038/s43018-022-00403-z. Epub 2022 Jul 4. PubMed |
| FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits. Tsai JW, Cejas P, Wang DK, Patel S, Wu DW, Arounleut P, Wei X, Zhou N, Syamala S, Dubois FPB, Crane A, Pelton K, Vogelzang J, Sousa C, Baguette A, Chen X, Condurat AL, Dixon-Clarke SE, Zhou KN, Lu SD, Gonzalez EM, Chacon MS, Digiacomo JJ, Kumbhani R, Novikov D, Hunter J, Tsoli M, Ziegler DS, Dirksen U, Jager N, Balasubramanian GP, Kramm CM, Nathrath M, Bielack S, Baker SJ, Zhang J, McFarland JM, Getz G, Aguet F, Jabado N, Witt O, Pfister SM, Ligon KL, Hovestadt V, Kleinman CL, Long H, Jones DTW, Bandopadhayay P, Phoenix TN. Cancer Res. 2022 Sep 2;82(17):2980-3001. doi: 10.1158/0008-5472.CAN-22-0671. PubMed |
| Curaxin CBL0137 inhibits endothelial inflammation and atherogenesis via suppression of the Src-YAP signalling axis. Ding H, Jiang M, Lau CW, Luo J, Chan AM, Wang L, Huang Y. Br J Pharmacol. 2023 Apr;180(8):1168-1185. doi: 10.1111/bph.16007. Epub 2022 Dec 29. PubMed |
| Thioridazine protects against disturbed flow-induced atherosclerosis by inhibiting RhoA/YAP-mediated endothelial inflammation. Jiang MC, Ding HY, Huang YH, Cheng CK, Lau CW, Xia Y, Yao XQ, Wang L, Huang Y. Acta Pharmacol Sin. 2023 Oct;44(10):1977-1988. doi: 10.1038/s41401-023-01102-w. Epub 2023 May 22. PubMed |
| Functional evaluation of germline TP53 variants identified in Brazilian families at-risk for Li-Fraumeni syndrome. Abreu RBV, Pereira AS, Rosa MN, Ashton-Prolla P, Silva VAO, Melendez ME, Palmero EI. Sci Rep. 2024 Jul 26;14(1):17187. doi: 10.1038/s41598-024-67810-3. PubMed |
| PPARgamma drives mitochondrial stress signaling and the loss of atrial cardiomyocytes in newborn mice exposed to hyperoxia. Cohen ED, Roethlin K, Yee M, Woeller CF, Brookes PS, Porter GA Jr, O'Reilly MA. Redox Biol. 2024 Oct;76:103351. doi: 10.1016/j.redox.2024.103351. Epub 2024 Sep 12. PubMed |
| Efficient suppression of premature termination codons with alanine by engineered chimeric pyrrolysine tRNAs. Awawdeh A, Tapia A, Alshawi SA, Dawodu O, Gaier SA, Specht C, Beaudoin JD, Tharp JM, Vargas-Rodriguez O. Nucleic Acids Res. 2024 Dec 11;52(22):14244-14259. doi: 10.1093/nar/gkae1048. PubMed |
| Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma. Sato K, Faraji F, Cervantes-Villagrana RD, Wu X, Koshizuka K, Ishikawa T, Iglesias-Bartolome R, Chen L, Miliani de Marval PL, Gwaltney SL, Adler B, Gutkind JS. Cancer Lett. 2025 Mar 1;612:217467. doi: 10.1016/j.canlet.2025.217467. Epub 2025 Jan 16. PubMed |
| An engineered glutamic acid tRNA for efficient suppression of pathogenic nonsense mutations. Specht C, Tapia A, Penrod S, Soriano GA, Awawdeh A, Alshawi SA, White CA, Beaudoin JD, Doud EH, Vargas-Rodriguez O, Huang Y, Tharp JM. Nucleic Acids Res. 2025 Jun 20;53(12):gkaf532. doi: 10.1093/nar/gkaf532. PubMed |
| Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancer. Ahmad F, White M, Yamamoto K, Crooks DR, Agarwal S, Yang Y, Capaldo B, Raj S, Alilin AN, Ton A, Adler S, Seidel J, Olkowski C, Cherukuri MK, Choyke PL, Kelly K, Brender JR. Neoplasia. 2025 Dec;70:101235. doi: 10.1016/j.neo.2025.101235. Epub 2025 Oct 7. PubMed |
| AICAr Inhibition of cardiomyocyte autophagy promotes p62-dependent NRF2 expression and protection against doxorubicin toxicity. Fassett EK, Mayer B, Fassett JT. Cell Mol Life Sci. 2025 Nov 13;82(1):395. doi: 10.1007/s00018-025-05905-4. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.